微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 10.88% | 22.11% | 31.72% | 21/159 | 4.13% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 8.26% | 43.15% | 148.05% | 16/159 | 2.59% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.33% | 3.1% | -68.53% | 24/159 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 10.58% | 11.25% | 18.74% | 28/159 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 8.91% | 0.34% | 54.42% | 31/159 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 5.77% | 3.59% | 78.64% | 31/159 | 1.5% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.23% | -6.92% | -66.04% | 31/159 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 9.51% | -26.51% | 7.09% | 47/159 | 0.78% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 8.88% | -31.48% | 59.43% | 37/159 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 5.57% | -32.65% | 60.52% | 43/159 | 2.25% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.47% | -27.41% | -73.18% | 27/159 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 12.94% | -38.96% | -0.15% | 31/159 | 0.9% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 12.96% | -19.2% | 56.71% | 16/159 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 8.27% | -16.04% | 73.01% | 25/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 4.78% | -7.54% | -77.45% | 16/159 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 21.2% | -5.53% | 32.17% | 19/159 | 3.73% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 16.04% | -6.42% | 62.84% | 14/159 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 9.85% | -9.22% | 90.52% | 21/159 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 5.17% | -11.93% | -76.96% | 11/159 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 22.44% | 1.68% | 30.92% | 16/159 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 17.14% | -0.52% | 57.97% | 10/159 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 10.85% | -2.86% | 84.84% | 12/159 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 5.87% | -2% | -73.4% | 10/159 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 22.07% | -1.69% | 28.09% | 11/159 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 17.23% | -0.63% | 54.25% | 4/159 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 11.17% | -5.26% | 86.48% | 8/159 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 5.99% | -5.67% | -73.32% | 8/159 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 22.45% | -3.44% | 29.47% | 8/159 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 17.34% | -2.58% | 47.07% | 8/159 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 11.79% | -5.3% | 85.67% | 8/159 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 6.35% | -4.65% | -72.69% | 5/159 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 23.25% | -4.56% | 30.62% | 14/159 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 17.8% | -1.17% | 42.97% | 8/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 12.45% | -1.03% | 86.94% | 5/159 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 6.66% | -0.15% | -72.66% | 6/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 24.36% | 14.91% | 35.26% | 16/159 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 18.01% | 11.31% | 43.16% | 8/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 12.58% | 11.62% | 88.61% | 10/159 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 6.67% | 11.91% | -68.54% | 6/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |